National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 10 of 1989)

Administered by Department of Health, Disability and Ageing

Legislation au F2007B01083 Not in force Legislative Instrument

Legislation content

 

 

 

COMMONWEALTH OF AUSTRALIA

NATIONAL HEALTH ACT 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUB-SECTION 85(2AA)

 

No. PB10 of 1989

 

 

I, JEFFREY ALLAN HARMER, Acting Principal Advisor, Health Care Access Division, Department of Community Services and Health and Delegate of the Minister of State for Community Services and Health, pursuant to sub-section 85(2AA) of the National Health Act 1953, hereby make the following Declaration:

 

 

1. This Declaration shall come into operation on 1 December 1989.

 

2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

 

THE SCHEDULE

 

Insulin, Biphasic

Insulin Zinc Suspension (Amorphous)

Vasopressin Tannate

Crystal Violet B.P. 1980

Testosterone B.P.

 

 

Dated this seventeenth day of November 1989.

 

 

 

 

J.A. HARMER

ACTING PRINCIPAL ADVISOR

HEALTH CARE ACCESS DIVISION

DELEGATE OF THE MINISTER OF STATE FOR COMMUNITY SERVICES AND HEALTH

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.